Align Technology, Inc., which is based in Tempe, Arizona, ( ALGN ) designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists. Valued at $11.2 billion By market capitalization, the firm also produces software for dental labs and dentists. The top producer of clear aligners is anticipated to report its financials shortly. first-quarter earnings For the year 2025 following the close of trading on Wednesday, April 30.
Before the event, analysts anticipate ALGN will report a earnings of $1.52 per share On a diluted basis, this represents a decrease of 6.2%. $1.62 per share In the corresponding period from the previous year, the company failed to meet the average analyst expectations in three out of the last four quarters, with one instance where they surpassed these predictions.
More Top Stocks Daily: Explore Wall Street's most talked-about stories through Massima's Active Investor newsletter.
For the entire year, experts anticipate ALGN will report earnings per share (EPS) of $8.04, marking an increase of 14.7% from $7.01 last year. fiscal 2024 Its earnings per share (EPS) are anticipated to increase by 11.3% year over year to reach $8.95 in fiscal 2026.
The ALGN stock has significantly lagged behind the performance of the S&P 500. $SPX ) 4.2% losses In the last 52 weeks, regarding the shares down 54.9% During this time frame, it also lagged behind the Health Care Select Sector SPDR Fund’s performance. XLV ) 6.9% dip during the same period.
The poor performance of ALGN can mostly be traced back to issues in the U.S. market, such as the effect of a rising U.S. dollar value. reduced demand for Clear Aligner sales These elements led to decreased earnings per share, along with strain on performance indicators like gross and operating margins because of exchange rate variations and restructuring expenses.
On Feb. 5, ALGN stock finished the day slightly higher. after reporting its Q4 results Its adjusted earnings per share (EPS) came in at $2.44, beating analysts' predictions of $2.43. However, the firm reported revenues of $995.2 million, which fell slightly below market estimates of $997 million. Looking ahead to the first quarter, ALGN anticipates their revenue will be between $965 million and $985 million.
Analysts’ general view on ALGN stock appears optimistic, holding an overall "Moderate Buy" recommendation. Among the 13 financial analysts evaluating this stock, nine endorse a "Strong Buy," one proposes a "Moderate Buy," two suggest maintaining a position ("Hold"), and another advises a cautious approach with a "Moderate Sell." The collective forecast places ALGN’s average price target at $254.50, which implies a substantial potential increase of approximately 76.3% from present values.
Upon release, Neha Panjwani did not hold (directly or indirectly) any stakes in the securities mentioned in this article. This piece contains only informational content and should be used as such. To learn more, please refer to the Massima Disclosure Policy. here .
More news from Massima
・ Elliott Management Is Purchasing Shares in This European Firm Hoping for a Rebound. Should You Consider It?
・ 3 Dividend Kings You Might Overlook – Wall Street Foresees Significant Potential in These Choices
・ 1 Stock to Consider for Security Amid Current Volatility
・ DARPA Has Chosen IonQ, Marking a Significant Victory for the Quantum Computing Firm. Does This Make It a Good Time to Purchase IONQ Stock During Its Drop?